This week's antitrust and data privacy updates are as below - Facebook warned by European Commission over Potential Antitrust Breach The European Commission has...
Read more about Weekly Antitrust and Data Privacy UpdatesTag: European Commission
Weekly Antitrust and Data Privacy Updates
This week's antitrust and data privacy updates are - Google to face more antitrust charges in the EU In a streak of antitrust proceedings...
Read more about Weekly Antitrust and Data Privacy UpdatesWeekly Anti-Trust and Privacy Updates
This week's Antitrust Updates are as follows: Optus Data Breach – Australian Government Blames the Company over the Breach The Australian telecommunication giant, Optus, was...
Read more about Weekly Anti-Trust and Privacy UpdatesCASE BRIEF : European Commission vs. Union of India
Facts The Petitioner, the European Union filed two writ petitions seeking two of the orders passed by the Controller General of Patents to be set...
Read more about CASE BRIEF : European Commission vs. Union of IndiaLatest Updates on Antitrust – November, 2021 – Part II
This is a rundown of last week's news updates on Antitrust: Google loses $2.8 billion as antitrust fine to EU Court The Luxembourg-based EU General...
Read more about Latest Updates on Antitrust – November, 2021 – Part IILatest Updates on Antitrust – October 2021 – Part II
This is a rundown of last week’s news updates on Antitrust: Allegations of Amazon India's anticompetitive practices sparks demand for US antitrust probe Ecommerce giant...
Read more about Latest Updates on Antitrust – October 2021 – Part IILatest Updates on Antitrust – September, 2021 – Part IV
This is a rundown of last week’s news updates on Antitrust: Google sues Competition Commission of India (CCI) over investigation leak Search engine giant Google...
Read more about Latest Updates on Antitrust – September, 2021 – Part IVRestricting ‘Pay-for-Delay’ Agreements
This post discusses recent fines imposed on pharmaceutical companies for pay-for-delay agreements and examines their impact on market competition and drug pricing. It analyses regulatory measures and the ongoing debate over the balance between innovation and consumer interests.
Read more about Restricting ‘Pay-for-Delay’ Agreements